Personalized medicine in rheumatoid arthritis: methotrexate polyglutamylation revisited-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Personalized medicine in rheumatoid arthritis: methotrexate polyglutamylation revisited

Published:2018-09-03 Issue:6 Volume:3 Page:331-334
ISSN:2380-8993
Container-title:Expert Review of Precision Medicine and Drug Development
language:en
Short-container-title:Expert Review of Precision Medicine and Drug Development

Author:

Muller Ittai B.¹,Hebing Renske F.²,Jansen Gerrit³,Nurmohamed Mike T.²³,Lems Willem F.³,Peters Godefridus J.⁴,de Jonge Robert¹

Affiliation:

1. Department of Clinical Chemistry, VU University Medical Center, Amsterdam, The Netherlands

2. Reade Research, Amsterdam Rheumatology and immunology Center, Amsterdam, The Netherlands

3. Amsterdam Rheumatology and immunology Center, VU University Medical Center, Amsterdam, The Netherlands

4. Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands

Funder

Reumafonds

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/23808993.2018.1517025

Reference25 articles.

1. Karnofsky memorial lecture. Ode to methotrexate.

2. Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers

3. Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis

4. Drug Insight: resistance to methotrexate and other disease-modifying antirheumatic drugs—from bench to bedside

5. Folylpoly-γ-glutamate synthetase: A key determinant of folate homeostasis and antifolate resistance in cancer

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic‐pharmacodynamic modelling and simulation of methotrexate dosing in patients with rheumatoid arthritis;British Journal of Clinical Pharmacology;2024-07-05

2. Erythrocyte Folyl Polyglutamate Synthetase Activity Profiling as a Potential Tool for the Prediction of Methotrexate Efficacy and Toxicity in Rheumatoid Arthritis;Future Pharmacology;2023-11-06

3. Can Pharmacogenetic Variants in TPMT, MTHFR and SLCO1B1 Genes Be Used as Potential Markers of Outcome Prediction in Systemic Sclerosis Patients?;International Journal of Molecular Sciences;2023-05-10

4. Pharmacokinetics of oral and subcutaneous methotrexate in red and white blood cells in patients with early rheumatoid arthritis: the methotrexate monitoring trial;Annals of the Rheumatic Diseases;2022-12-21

5. Therapeutic drug monitoring for cytotoxic anticancer drugs: Principles and evidence-based practices;Frontiers in Oncology;2022-12-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3